NCNA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

NuCana (NCNA) Earnings Date & Reports

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NCNA is expected to report earnings to fall 96.57% to 0 cents per share on May 15

Q1'24

Est.

$0.00

Q4'23

Missed

by $0.03

Q3'23

Est.

$0.00

Q2'23

Est.

$0.00

Q1'23

Est.

$0.00

The last earnings report on March 20 showed earnings per share of -3 cents, missing the estimate of 0 cents. With 85.25K shares outstanding, the current market capitalization sits at 5.45M.

View a ticker or compare two or three

Compare

NCNA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NCNA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of novel anti-cancer medicines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3 Lochside Way

Phone

+44 1313571111

Employees

Web

https://www.nucana.com